Stay updated on Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial

Sign up to get notified when there's something new on the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed. Additionally, a significant piece of information regarding the modernization of ClinicalTrials.gov data ingest in July 2025 has been deleted.
    Difference
    0.7%
    Check dated 2025-07-04T03:55:36.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025.
    Difference
    0.6%
    Check dated 2025-06-19T19:32:49.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.1 to v2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T11:11:24.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    1.0%
    Check dated 2025-05-29T05:55:06.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T13:54:04.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    The page has undergone significant content removal, including the deletion of the study's purpose, inclusion and exclusion criteria, and details about the treatment trial for genetic obesity. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    12%
    Check dated 2025-04-16T01:49:12.000Z thumbnail image

Stay in the know with updates to Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page.